Lactate Dehydrogenase as a Biomarker for Assessment of COVID-19 Prognosis in Severe and Critically Ill Patients in Nepal: A Single-centered Retrospective Study. One Health J. Nep. [Internet]. 2023 Dec. 31 [cited 2026 Jul. 19];3(6):1-5. Available from: https://www.nepjol.info/index.php/ohjn/article/view/63320